Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Apax Partners leads race for Finastra’s treasury unit in $2bn carve-out from Vista
Apax Partners leads race for Finastra’s treasury unit in $2bn carve-out from Vista Apax Partners is in pole position to acquire the treasury and capital markets division of Finastra in a deal valued at around $2bn, including debt, according to sources cited by...
Morgan Stanley launches evergreen private equity fund targeting co-investments and secondaries
Morgan Stanley launches evergreen private equity fund targeting co-investments and secondaries Morgan Stanley Investment Management has introduced the North Haven Private Assets Fund, its first evergreen private equity fund designed to provide high-net-worth investors...
Ares raises $20bn in Q1 as private credit inflows drive AUM to $546bn
Ares raises $20bn in Q1 as private credit inflows drive AUM to $546bn Ares Management has raised more than $20bn in the first quarter of 2025, setting a new fundraising record for the firm and pushing total assets under management to nearly $546bn — a 27% increase...